IBAB Overzicht aandelen
Ion Beam Applications SA ontwikkelt, produceert en ondersteunt medische apparatuur en softwareoplossingen voor kankerbehandelingen in België, de Verenigde Staten en internationaal.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 3/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 1/6 |
Ion Beam Applications SA Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | €13.40 |
| 52 Week Hoogtepunt | €15.14 |
| 52 Week Laag | €9.31 |
| Bèta | 0.99 |
| 11 maand verandering | -0.74% |
| 3 maanden verandering | 10.38% |
| 1 Jaar Verandering | 33.47% |
| 33 jaar verandering | -20.90% |
| 5 jaar verandering | -7.59% |
| Verandering sinds IPO | -73.96% |
Recent nieuws en updates
Ion Beam Applications SA (EBR:IBAB) Shares Fly 25% But Investors Aren't Buying For Growth
Oct 08
Is Now An Opportune Moment To Examine Ion Beam Applications SA (EBR:IBAB)?
Sep 19Recent updates
Ion Beam Applications SA (EBR:IBAB) Shares Fly 25% But Investors Aren't Buying For Growth
Oct 08Is Now An Opportune Moment To Examine Ion Beam Applications SA (EBR:IBAB)?
Sep 19It's Unlikely That The CEO Of Ion Beam Applications SA (EBR:IBAB) Will See A Huge Pay Rise This Year
Jun 06Further Upside For Ion Beam Applications SA (EBR:IBAB) Shares Could Introduce Price Risks After 29% Bounce
Mar 25Is Ion Beam Applications (EBR:IBAB) Using Too Much Debt?
Nov 07Ion Beam Applications (EBR:IBAB) Has Some Way To Go To Become A Multi-Bagger
Oct 05Ion Beam Applications (EBR:IBAB) Is Investing Its Capital With Increasing Efficiency
Jan 31Is Ion Beam Applications (EBR:IBAB) A Risky Investment?
Sep 28Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet
Jun 01Ion Beam Applications' (EBR:IBAB) Returns On Capital Are Heading Higher
May 29Does Ion Beam Applications SA (EBR:IBAB) Have A Place In Your Dividend Stock Portfolio?
Apr 20Is Ion Beam Applications (EBR:IBAB) A Risky Investment?
Mar 30Should You Use Ion Beam Applications' (EBR:IBAB) Statutory Earnings To Analyse It?
Feb 10What Type Of Shareholders Make Up Ion Beam Applications SA's (EBR:IBAB) Share Registry?
Jan 06Does This Valuation Of Ion Beam Applications SA (EBR:IBAB) Imply Investors Are Overpaying?
Dec 10Ion Beam Applications' (EBR:IBAB) Shareholders Are Down 64% On Their Shares
Nov 17
Ion Beam Applications SA (EBR:IBAB) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Aug 20Estimating The Intrinsic Value Of Ion Beam Applications SA (EBR:IBAB)
Jul 21Rendement voor aandeelhouders
| IBAB | BE Medical Equipment | BE Markt | |
|---|---|---|---|
| 7D | -3.3% | -3.9% | -2.0% |
| 1Y | 33.5% | 14.7% | 8.5% |
Rendement versus industrie: IBAB exceeded the Belgian Medical Equipment industry which returned 14.7% over the past year.
Rendement versus markt: IBAB exceeded the Belgian Market which returned 8.5% over the past year.
Prijsvolatiliteit
| IBAB volatility | |
|---|---|
| IBAB Average Weekly Movement | 6.8% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in BE Market | 6.5% |
| 10% least volatile stocks in BE Market | 2.2% |
Stabiele aandelenkoers: IBAB's share price has been volatile over the past 3 months compared to the Belgian market.
Volatiliteit in de loop van de tijd: IBAB's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1986 | 1,943 | Olivier Legrain | www.iba-worldwide.com |
Ion Beam Applications SA ontwikkelt, produceert en ondersteunt medische apparatuur en softwareoplossingen voor kankerbehandelingen in België, de Verenigde Staten en internationaal. Het bedrijf is actief via de segmenten Protontherapie en andere versnellers en Dosimetrie. Het segment protontherapie en andere versnellers ontwikkelt, fabriceert en onderhoudt medische en industriële deeltjesversnellers en protontherapiesystemen.
Ion Beam Applications SA Samenvatting
| IBAB fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €391.03m |
| Inkomsten(TTM) | €7.85m |
| Inkomsten(TTM) | €465.75m |
49.8x
Koers/Winstverhouding0.8x
P/S-verhoudingIs IBAB overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| IBAB resultatenrekening (TTM) | |
|---|---|
| Inkomsten | €465.75m |
| Kosten van inkomsten | €306.52m |
| Brutowinst | €159.24m |
| Overige uitgaven | €151.39m |
| Inkomsten | €7.85m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Nov 21, 2024
| Winst per aandeel (EPS) | 0.27 |
| Brutomarge | 34.19% |
| Nettowinstmarge | 1.69% |
| Schuld/Eigen Vermogen Verhouding | 35.9% |
Hoe presteerde IBAB op de lange termijn?
Bekijk historische prestaties en vergelijking